OR (95% I.C.) | p value | |
---|---|---|
Univariate analysis | ||
Gender (M vs F) | 0.27 (0.16-0.45) | <0.001 |
Age (≥35 vs<35) | 0.44 (0.27-0.72) | <0.001 |
HIV infection (yes vs no) | 0.71 (0.43-1.18) | 0.100 |
Cotrimoxazole prophylaxis (yes vs no) | 0.20 (0.14-0.61) | <0.001 |
Antiretroviral treatment (yes vs no) | 0.49 (0.24-1.01) | 0.030 |
Multivariate analysis | ||
Gender (M vs F) | 0.29 (0.17-0.51) | <0.001 |
Age (≥35vs<35) | 0.46 (0.27-0.77) | 0.004 |
HIV infection (yes vs no) | 0.84 (0.47-1.5) | 0.568 |
Cotrimoxazole prophylaxis (yes vs no) | 0.31 (0.11-0.84) | 0.022 |
Antiretroviral treatment (yes vs no) | 1.18 (0.44-3.15) | 0.735 |